Probióticos en el tratamiento de la estomatitis subprotésica asociada a candida albicans. revisión de alcance.

Abstract

Denture stomatitis (DS) associated with Candida species has been reported in several clinical and microbiological studies. DS grade II and III according to Newton; it involves the use of antifungal therapy, the effect of this one may be affected by drug interactions or a decrease in the effect associated with increasing antifungal resistance. Therefore, the present review offers an approach to the state of the art on the use of probiotic lactobacilli as adjunctive therapies in the treatment of lesions of subprosthetic stomatitis associated with C. albicans. A scoping review was carried out using the databases PubMed, Scielo, LILACS and Google Scholar, in order to search for clinical studies published in English and Spanish during the last 5 years, which described the action of probiotic lactobacilli strains such as therapy in ESP associated with C. albicans. From this search, 2,633 articles were found, after discarding those unrelated to the objective and filtering according to the inclusion and exclusion criteria, 46 articles were selected; discarding 33 duplicates, finally obtaining 12 articles. In general, the use of probiotic lactobacilli as a treatment for ESP associated with C. albicans showed favorable results. However, the few clinical trials available do not allow ratifying or extrapolating these effects to a larger population, also observing quite heterogeneous methodologies and the presence of intervening variables that see the results, which indicates the need to establish clinical trials with standardized protocols that lead to obtaining statistically significant results.